MediWound Q1 2024 GAAP EPS $(1.05) Misses $(0.41) Estimate, Sales $4.964M Beat $4.668M Estimate
Portfolio Pulse from Benzinga Newsdesk
MediWound reported its Q1 2024 financial results with a GAAP EPS of $(1.05), missing the estimate of $(0.41). However, the company reported sales of $4.964 million, beating the estimate of $4.668 million.
May 29, 2024 | 11:02 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MediWound's Q1 2024 financial results showed a significant miss on GAAP EPS, which came in at $(1.05) compared to the estimated $(0.41). However, the company reported better-than-expected sales of $4.964 million, surpassing the estimate of $4.668 million.
The significant miss on GAAP EPS is likely to weigh negatively on the stock price in the short term. However, the better-than-expected sales may provide some support, leading to a neutral overall impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100